When business operations are resumed in times of the Corona pandemic, safety and health protection have top priority. For this reason, the nationwide occupational health and safety standard COVID-19 has been in force since April 16, 2020.
The first Asia-Pacific subsidiary, the Philippines, of the German-based Aristo Pharma GmbH has received the operating license from the Philippine Food and Drug Administration. The company is thus considered a fully-fledged pharmaceutical company. Accordingly, the newest sales location has a license to distribute and sell its licensed pharmaceutical products on the local pharmaceutical market.
In addition, the company can now start applying for registration of Aristo Pharma products. The certificate was granted on June 18, 2019. The license includes the activities as importer, wholesaler and exporter.
We are pleased to be opening up the Asia-Pacific market with the Group's newest sales location.